Adrian is a seasoned IP lawyer who relishes immersing himself in his client’s technology, product roadmap and patent/IP strategy. He is regularly involved in the negotiation and drafting of technology licence agreements and other contracts with a heavy IP element, such as R&D collaborations, joint ventures, grant funding agreements and other commercial arrangements. He also advises on the EC and UK competition law aspects of these agreements, and issues relating to technical standardisation, essential IPR and patent pooling.

Adrian has a wealth of experience in handling the IP aspects of University spin-outs, IPOs and other major corporate transactions and disputes, including for FTSE 100 and Fortune 500 corporations. He is also a valued patent litigator, having recently advised on disputes involving pharmaceuticals, somatic cell therapy, semiconductor chip design, inkjet printing technology, digital compression algorithms, LCD flat-panel technology, telecoms and pharmaceuticals. He also frequently helps clients with disputes involving confidential information, database rights, trade marks, copyright and designs.

Adrian publishes and speaks regularly on a variety of intellectual property issues.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Planning for a TechBio Exit – what does 'good' look like?

5 février 2024
Quick read

par Nicholas Vollers et Adrian Toutoungi

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

High Court judgment on misrepresentations made in preclinical research programme: a cautionary tale for UK universities

1 février 2024

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Word on the street at the J.P. Morgan Healthcare Conference 2024

17 janvier 2024
In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Further recognition for our market-leading work in the life sciences sector

21 septembre 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus